Tiaquel

Quick links to important sections

Tiaquel

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tiaquel

What is Tiaquel?

Tiaquel is a pharmaceutical medication containing the active substance quetiapine. It belongs to a group of medicines known as antipsychotics. These medications work by affecting the way certain chemical messengers, or neurotransmitters, transmit signals within the brain.

Primary Mechanism

The active ingredient in Tiaquel interacts with various receptors in the brain, specifically targeting dopamine and serotonin pathways. By modulating the activity of these neurotransmitters, the medication helps to manage and stabilize the chemical imbalances associated with certain mental health conditions.

Therapeutic Use

Tiaquel is primarily used to treat conditions that affect how a person thinks, feels, or behaves. These include:

  • Schizophrenia: A condition where a person may hear or see things that are not there, believe things that are not true, or feel unusually suspicious or confused.
  • Bipolar Disorder: A condition characterized by significant mood swings. These may include episodes of mania (feeling highly excited, overactive, or unusually irritable) and episodes of depression (feeling very sad, guilty, or lacking energy).

In some instances, Tiaquel may be used as an add-on treatment for major depressive episodes in patients who have not had an adequate response to other antidepressant medications. It serves to help balance mood and improve the overall symptoms associated with these psychological disorders.

Regulatory References

  1. NIH: Atypical Antipsychotics (SGAs)
  2. MedlinePlus - Quetiapine

What side effects are possible with Tiaquel?

Possible Side Effects and Safety Information

The safety profile of Tiaquel (Quetiapine Fumarate) is structured by regulatory bodies based on documented adverse reactions and specific safety constraints.

Adverse Reaction Classifications

Adverse effects are formally classified by frequency, with many occurring in the Metabolism and Nutrition Disorders and Nervous System Disorders categories.

  • Very Common (ge 1/10): Somnolence (drowsiness), dizziness, dry mouth, and an increase in total body weight.
  • Common (ge 1/100 to < 1/10): Orthostatic hypotension (dizziness upon standing), tachycardia (fast heartbeat), constipation, and the appearance of Extrapyramidal Symptoms (EPS).
  • Uncommon (ge 1/1,000 to < 1/100): Seizures and syncope (fainting).

Serious Safety Risks

The official labeling documents several serious adverse reactions, which include rare but critical events. These are often tied to regulatory warnings, such as Neuroleptic Malignant Syndrome (NMS), which is a rare, potentially fatal symptom complex. The label also notes the risk of Tardive Dyskinesia (involuntary, repetitive movements) and an increased risk of Suicidal Thoughts and Behaviors in young adults taking the medication for depressive indications.

Population and Duration-Related Safety

Quetiapine's safety profile includes constraints for specific groups. The drug is not approved for use in older adults with dementia-related psychosis due to a documented increased risk of death. Metabolic changes, including hyperglycemia and alterations in lipids, are associated with long-term exposure. Conversely, effects like orthostatic hypotension are often most pronounced during treatment initiation or dose changes. Discontinuation syndrome, characterized by symptoms like insomnia, may occur upon abrupt cessation.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Tiaquel (Quetiapine Fumarate) is primarily characterized by the exaggeration of its known effects on the central nervous and cardiovascular systems, as documented in official regulatory labeling. Due to the potential for severe and life-threatening outcomes, immediate medical attention is required for any suspected overdose.


Documented Manifestations and Actions

Classification Aspect Official Regulatory Statements
Documented Overdose Signs Somnolence, tachycardia (increased heart rate), and hypotension (low blood pressure). Severe toxicity may advance to coma and delirium.
Life-Threatening Risks Potential for severe CNS depression and the occurrence of Neuroleptic Malignant Syndrome (NMS), a rare but potentially fatal condition.
Antidote Status No specific antidote is known for Quetiapine Fumarate.
Required Emergency Action Symptomatic and supportive treatment in a hospital setting is mandated. Continuous ECG monitoring is required.

Monitoring and Procedural Notes

The management strategy for overdose relies on intensive supportive measures, including maintaining a patent airway and providing adequate ventilation. Due to the drug's properties, certain procedures are advised: for treating overdose-related hypotension, regulatory guidance suggests avoiding epinephrine and dopamine. Furthermore, the Extended Release (XR) formulation may require an extended observation period due to its delayed absorption profile, which impacts the timing of toxic effects.

Therapeutic Uses of Tiaquel

Tiaquel is applied for mood and thought stabilization. This medication is generally used to help with conditions characterized by periods of heightened symptoms across major psychiatric domains.

Therapeutic Focus and Relief

Tiaquel is applied in addressing core indications: Schizophrenia, acute manic episodes and depressive episodes associated with Bipolar Disorder, and as an add-on treatment for Major Depressive Disorder.

For patients experiencing Schizophrenia, it is relevant for managing symptom clusters that create noticeable interference with reality, such as hallucinations and delusions. In acute manic episodes, it contributes to improved comfort by addressing symptoms like racing thoughts and impulsivity. Furthermore, it supports the patient during difficult episodes of bipolar depression and is generally considered relevant for the long-term goal of reducing the risk of symptom return.

“The medication provides support that helps ease the overall symptom burden during periods of high distress and contributes to maintaining a sense of daily stability.”


Quick Fact: Relief for Severe Thought Disorganization Tiaquel is commonly used when symptoms that interfere with daily functioning escalate rapidly, requiring short-term symptomatic assistance to support maintaining functional stability.

Eligibility and Restrictions for Use

Eligibility for Tiaquel: Official Regulatory Status

Tiaquel is contraindicated for use in patients with a known hypersensitivity to the active substance, quetiapine fumarate, or to any of its components. The medicine is also absolutely contraindicated for patients who are simultaneously taking strong CYP3A4 inhibitors, such as certain HIV-protease inhibitors and azole-antifungal agents, due to the risk of increased drug exposure.

Population-Specific Non-Eligibility and Restrictions

Category Regulatory Eligibility Status
Elderly with Dementia-Related Psychosis Not approved for use due to an increased risk of death, as documented in an FDA Boxed Warning.
Pediatric Patients Approved for use in adolescents (ge 13 years) for Schizophrenia and children/adolescents (ge 10 years) for Bipolar Mania. Use for other indications is not recommended in those under 18.
Hepatic Impairment Use must be with caution; a lower starting dose and slower dose titration are specified by regulators due to extensive liver metabolism.
Pregnancy Not generally recommended; use should only occur if the potential benefit justifies the potential risk. Neonates exposed in the third trimester are at risk for withdrawal symptoms.
Lactation (Breastfeeding) Use is not recommended according to official labels, though some regulators advise caution while noting low transfer into breast milk.
Cardiovascular Risk Use is advised with caution in patients with known cardiovascular or cerebrovascular disease due to the risk of orthostatic hypotension.

Connection to the overall eligibility profile

Regulatory documents define who can and cannot use this medicine by establishing absolute prohibitions (contraindications), setting specific minimum age thresholds for approved indications, and restricting use in high-risk groups, such as elderly patients with dementia. These classifications mandate caution or exclusion based on physiological state and concurrent medication use.

What should I know about interactions with other medicines?

Tiaquel Interactions with other medicines and products

Interactions with Tiaquel (quetiapine) primarily involve the metabolism of the drug and additive effects on the central nervous system (CNS) and heart function, as documented in regulatory labeling.

Metabolically Significant Interactions

Quetiapine is metabolized by the enzyme Cytochrome P450 3A4 (CYP3A4). Concomitant use with strong inhibitors of this enzyme, such as certain antifungals (ketoconazole) or antivirals (ritonavir), can significantly increase quetiapine concentrations. Regulatory documents mandate a substantial reduction in the quetiapine dose when these potent CYP3A4 inhibitors are coadministered. Conversely, strong CYP3A4 inducers, such as certain antiepileptic medicines (phenytoin, carbamazepine) or the herbal supplement St. John's Wort, can decrease quetiapine plasma levels. When an inducer is coadministered for longer than a short-term period, the quetiapine dose typically requires a significant increase to maintain its therapeutic effect.

Pharmacodynamic Interactions

Coadministration with other CNS depressants, including alcohol and other centrally acting medicines, should be avoided or used with caution due to the risk of additive effects, such as increased sleepiness, sedation, and dizziness. Additionally, caution is required with medicines known to prolong the QT interval on the electrocardiogram, such as certain antiarrhythmics or other antipsychotics, as this combination can increase the risk of serious cardiac events.

Mechanism of Action

How Tiaquel Works: Mechanism of Action

Tiaquel exerts its action by engaging mechanisms that modulate receptor- or enzyme-mediated signaling within specific biological systems. Its core function involves targeted adjustment of key pathways associated with heightened or dysregulated physiological responses. The drug modifies early molecular steps and influences feedback regulation, leading to attenuation of physiological activity.


Modulation of Key Signaling Pathways

Tiaquel initiates signaling sequences that lead to downstream effects by targeting systems where specific transmitters or mediators dominate. This mechanistic domain covers the early molecular steps in the cascade, specifically affecting pathway activity that is subject to overactivation. The resulting effect involves a reduction in the concentration and duration of mediator activity, which leads to the establishment of a modified signaling equilibrium within the targeted pathways.


Regulation of Dysregulated Processes

Modification of these steps results in attenuation of heightened physiological responses, which determines a shift towards lower baseline activity within the relevant systems. The drug engages mechanisms that influence overactive or dysregulated processes driven by distinct signaling patterns, relevant in cascades where multiple layers of pathway activation occur. The resulting adjustments are a direct consequence of the molecular engagement.


Influence on Feedback Regulation

Tiaquel is involved in mechanisms that influence feedback regulation within pathways. This cluster is relevant in systems where targeted pathway adjustment is required for modifying downstream activity. The engagement with these mechanisms modulates the systemic physiological outcome resulting from targeted pathway modulation.

Dosage and Administration Information

How to Use Tiaquel (Quetiapine)

The following describes how the medicine is administered.


Administration Scope

Feature Immediate-Release (IR) Tablet Extended-Release (XR) Tablet
Route Oral (by mouth) Oral (by mouth)
Frequency Typically twice or three times daily (BID/TID) Once daily (QD)
With Food Can be taken with or without food Should be taken without food or with a light meal
Physical Form Swallowed whole Must be swallowed whole; do not split, chew, or crush

Dosing and Procedural Rules

Starting Treatment (Titration): Treatment begins with a low starting dose which is gradually increased over the first few days based on specific requirements for the intended use, a process known as titration.

Special Population Adjustments: Lower starting doses and slower titration schedules are used for elderly patients and individuals with known hepatic (liver) impairment.

Interacting Medications: The dose requires adjustment when co-administered with strong CYP3A4 inhibitors (requiring dose reduction) or CYP3A4 inducers (requiring dose increase).

Missed Dose: If a dose is missed, the next dose should be taken at the regularly scheduled time. A double dose should not be taken to make up for a missed one.

Stopping Treatment (Tapering): The drug is not to be stopped abruptly. When discontinuing, the dose is gradually reduced over a period of at least one to two weeks.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Tiaquel (Quetiapine Fumarate)

The clinical evidence for Tiaquel (Quetiapine Fumarate) is primarily based on Randomized Controlled Trials (RCTs) designed to explore how symptoms change over defined time intervals. This overview summarizes the structure of the research evaluated by regulatory authorities.


Evidence for Use in Schizophrenia

Research on Tiaquel was studied in short-term, placebo-controlled RCTs typically lasting about six weeks, examining core psychotic symptom scores in adults and adolescents. Studies reported that symptom scores measured in the study groups were different from those recorded in the placebo groups. The primary symptom change measurements are focused on the initial short-term phase, and there is limited information for controlled long-term functional outcomes.


Evidence for Use in Bipolar Disorder

The evidence base for Bipolar Disorder includes trials exploring both acute manic and acute depressive episodes. Research for acute mania included monotherapy and adjunctive RCTs studying symptom score changes in adults and youth. For acute bipolar depression, eight-week placebo-controlled RCTs described patterns of change in depressive symptom scores in adults that were different from the placebo group. The available evidence describes consistent patterns for adults, but subgroup findings for pediatric bipolar depression remain mixed.


Evidence for Use as an Adjunct in Major Depressive Disorder (MDD)

Research for MDD was conducted exclusively in short-term, adjunctive RCTs. The trials measured the difference in symptom scores and the proportion of patients achieving specific levels of symptom reduction when the extended-release formulation was added to an antidepressant. Studies indicated patterns where a specific dose level was associated with a change in symptom scores that was different from the change recorded in the placebo add-on group. Follow-up durations were limited to the initial six to eight weeks.


Long-Term Studies and Research Gaps

Long-term stability was explored through placebo-controlled maintenance trials lasting up to two years. Research describes patterns where the time to recurrence of mood events was recorded as shorter in the placebo groups compared to the continuation groups.

While acute symptom changes have been extensively evaluated, a significant research gap exists concerning long-term functional outcomes across all indications, as follow-up durations were limited in the primary controlled trials. The available data are predominantly focused on standardized symptom severity scores, with less information available from patient-reported outcomes or for long-term use in older adult populations.

Frequently Asked Questions (FAQ)

Common questions about Tiaquel (FAQ)


Q: What is the main difference between Tiaquel and other medicines used for the same thing?

Official documents classify Tiaquel as a Second-Generation Antipsychotic with a distinct pharmacological profile. Its core function involves blocking two key chemical messengers in the brain: dopamine D2 and serotonin 5-HT2 receptors. The specific way it balances its action on these and other receptor systems creates its unique therapeutic profile when compared to other medications in the same class.

Q: Is Tiaquel considered a long-term treatment option?

Yes, regulatory documents describe Tiaquel for long-term maintenance treatment for certain approved conditions, such as preventing recurrence in Bipolar Disorder. Studies have examined its continued use for this purpose over periods lasting up to two years.

Q: How quickly does Tiaquel usually start to work?

Clinical trials for some approved uses have shown a difference in symptom scores compared to placebo as early as one week after starting treatment. However, since the medicine often begins with a low dose that is gradually increased, the full therapeutic effect may take a longer time to be established.

Q: Are there any specific foods or drinks I should avoid while taking Tiaquel?

Official prescribing information states that grapefruit and grapefruit juice must be avoided because they can interfere with how the body metabolizes the medicine, potentially increasing its concentration. Additionally, alcohol is listed as needing caution due to the risk of additive effects like increased drowsiness and dizziness.

Q: Is it common for people to feel sleepy when starting Tiaquel?

Somnolence (drowsiness) is classified as a Very Common adverse reaction in official documents, meaning it is reported in 1 in 10 patients or more. This feeling of sleepiness is often most noticeable when treatment is initiated or when the dose is increased.

Q: Does Tiaquel have a risk of dependence or withdrawal?

Regulatory documents note the possibility of acute withdrawal symptoms if the medicine is stopped abruptly. For this reason, official guidelines specify that when discontinuing treatment, the dosage requires gradual reduction over a period of time. Official labels also address the topic of misuse in certain populations.

Q: Can Tiaquel affect my ability to drive or operate machinery?

Official labeling includes a warning that caution is necessary when operating hazardous machinery, including driving. This is because common side effects, such as drowsiness and dizziness, are known to potentially impair judgment and motor skills.

Q: Does Tiaquel show up on drug tests?

Official prescribing information notes that taking this medicine may cause false-positive results for certain substances, such as tricyclic antidepressants, on specific urine drug screening tests. If such a result occurs, the label advises that confirmatory testing should be considered.

Q: Is Tiaquel known to cause weight changes?

Weight gain is classified in official documents as a Very Common adverse reaction, reported in many patients. Furthermore, long-term exposure is associated with other metabolic changes, including alterations in blood sugar (hyperglycemia) and lipids (fats) in the blood.

Q: Is there a generic version of Tiaquel available?

Yes, the active ingredient, Quetiapine Fumarate, has had its generic versions approved by regulatory authorities. These generic formulations are marketed by various manufacturers and are available in both immediate-release and extended-release forms.

Q: How long does the effect of one dose of Tiaquel typically last?

The active compound has a relatively short terminal half-life (the time it takes for half the drug to be eliminated) of approximately 7 hours. However, the clinical effects of the medicine may last longer due to the action of an active metabolite and the availability of the extended-release formulation.

Q: How is Tiaquel described in official prescribing information regarding its use?

Official prescribing information states that it is approved for the treatment of multiple conditions. These include schizophrenia, episodes of mania and depression associated with bipolar disorder, and as an add-on treatment when prescribed alongside an antidepressant for major depressive disorder.

Q: Can people with heart conditions use Tiaquel?

Official guidelines advise that the medicine should be used with caution in patients with known cardiovascular or cerebrovascular disease. Caution is also advised regarding other medicines that can affect heart function, specifically those that can prolong the QT interval on an electrocardiogram.

Q: How does Tiaquel interact with over-the-counter pain relievers?

Regulatory documents do not specifically list all common over-the-counter pain relievers as contraindications. However, official information requires caution when taking Tiaquel with other agents that can cause increased sedation or affect heart function.

Q: What happens to the body if someone takes too much Tiaquel?

Reports of overdosage describe symptoms that are typically magnified versions of its known side effects. These include excessive sedation and dizziness, tachycardia (fast heart rate), and hypotension (low blood pressure). Major overdosage has been associated with reports of coma and death.

Q: Is there a particular time of day that is described as best for taking Tiaquel?

Official administration guidelines state that the immediate-release formulation is typically taken two or three times a day. The extended-release formulation is usually taken once daily and is often recommended for the evening or at bedtime to help manage potential daytime drowsiness.

Q: Is Tiaquel classified as a controlled substance?

No, the active ingredient in Tiaquel, Quetiapine, is not classified as a controlled substance under the U.S. Controlled Substances Act or equivalent regulatory scheduling in most major international jurisdictions.

Q: Are there long-term side effects noted in the regulatory documents for Tiaquel?

Yes, regulatory documents note that long-term exposure is associated with metabolic changes, including hyperglycemia and weight gain. Furthermore, chronic use carries a risk of developing involuntary movement disorders, such as Tardive Dyskinesia.

Q: What type of doctor usually prescribes Tiaquel?

Tiaquel is a prescription-only medicine used for complex psychiatric conditions. Prescribing is typically managed by healthcare providers specializing in mental health, such as psychiatrists, but may also be managed by other specialists or primary care physicians.

Q: Is it normal to feel anxious when first starting Tiaquel?

While official labeling lists anxiety as a possible side effect, it is not listed as a Very Common or Common effect during the initial treatment phase, unlike somnolence and dizziness. Patients who experience new or worsening anxiety symptoms generally seek guidance from a healthcare provider.

Q: What are the signs of an allergic reaction to Tiaquel?

The medicine is contraindicated for patients who have experienced a known hypersensitivity to the active ingredient. Signs of a potentially serious allergic reaction may include rash, hives, or swelling of the face, lips, tongue, or throat.

Q: Does the efficacy of Tiaquel change based on the patient's condition?

Yes, regulatory approvals are based on clinical evidence for specific conditions, and its efficacy profile may differ. The official indications and the recommended dosage strategies are unique for conditions such as schizophrenia, bipolar mania, bipolar depression, and major depressive disorder.

Q: Is a specific diet required while taking Tiaquel?

While a specific meal plan is not required, official warnings advise that items like grapefruit and grapefruit juice must be avoided. Additionally, the extended-release tablet requires a specific administration condition, as it must be taken without food or with only a light meal.

Q: What is the difference between an adverse event and a side effect for Tiaquel?

In regulatory language, an adverse event describes any unwanted medical occurrence observed during treatment, whether or not the drug caused it. A side effect (or adverse reaction) is a specific unwanted medical response for which there is evidence of a causal relationship with the drug.

Q: Can the cost of Tiaquel vary greatly?

Yes, the cost of the medication can fluctuate considerably based on whether the prescriber recommends the brand-name product or the generally less expensive generic formulation. Costs also vary based on insurance coverage, pharmacy, and the specific dosage strength.

Q: Can men and women expect different side effects from Tiaquel?

Official documents indicate that the medicine can increase levels of the hormone prolactin, which may lead to sex-specific side effects. These can include swelling of the breasts and menstrual changes in females, and decreased libido or erectile dysfunction in males.

How should Tiaquel be stored and disposed of?

How to Store and Dispose of Tiaquel?

The storage and disposal of Tiaquel (Quetiapine Fumarate) must strictly follow the conditions specified in official regulatory labeling to ensure product integrity and public safety.

Storage Requirement Official Condition
Temperature Store at 25 C (77 F), with excursions permitted up to 30 C (86 F). Do not freeze or refrigerate.
Protection The container must be kept tightly closed and the medicine must be protected from moisture.
Child Safety Keep this medication out of the sight and reach of children.

Disposal Instructions

Unused or expired tablets should not be disposed of via wastewater or household waste. Disposal must be performed according to local regulations for pharmaceutical waste. Consult a pharmacist regarding appropriate disposal programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tiaquel found in:

A-Z Index: